Get started

BioXcel Therapeutics, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

BTAI chart

Key stats

Market capitalization
85.168MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−7.12USD
Net income
−165.757MUSD
Revenue
375KUSD
Shares float
29.267M
Beta
2.07

About BioXcel Therapeutics, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Vimal D. Mehta
Website
bioxceltherapeutics.com
Headquarters
New Haven
Employees
183
Founded
2017
ISIN
US09075P1057

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in developing artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology. It also focuses on utilizing cutting-edge technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.

Ideas

BTAI | InformativeNASDAQ:BTAI Technical Analysis for NASDAQ:BTAI : If the price of BTAI breaks above the bullish line of $11.61, it may indicate a bullish signal, suggesting potential upward price movement. In this scenario, the target price could be set at $16.80. Conversely, if the price of BTAI breaks below
$BTAI - is it able to keep on the previous trend line?NASDAQ:BTAI oversold and should return to the range for the further trivial trading in 2 months. I believe, it go back. All pictures show that this drop need to be closed and forgotten as a bad dream. Good possible profit for the risky investors in a short enough range of time. Does not constitu
Long
1
$BTAI (Bioxcel Therapeutics - semi-year race with good tipsNASDAQ:BTAI - is it hoing to grow? My answer - it is almost ready to start. Shown a high level of correcton after the previous long wave, company would like to show nice profit for the investors to this kind of fields. NASDAQ:BTAI (Bioxcel Therapeutics) :: 21.46->50::+132%::Aug 2023 Does not co
Long
6
BioXcel Therapeutics Announces FDA Approval of IGALMIBTAI: BioXcel Therapeutics 2022-04-06 07:00:00 BioXcel Therapeutics Announces FDA Approval of IGALMI™ (dexmedetomidine) Sublingual Film for Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder in Adults
Long
BTAi Bullish news caused a beautiful pump on this overnight. Although it was looking bearish the news pushed us back up. I am watching 22.68 as it as held us up in premarket but my key levels are 21.40 and 18.91. These are area in interested in trying. As most of the market is bearish , this may attrac
Long
Added $BTAI Target 42.51 for 47.09% $BTAI Target 42.51 for 47.09% Or next add at 23.79 There is a bullish RSI divergence on the daily chart... I'd like to see this hold above that trendline... Just looking at indicators... if it holds I might even add a little more tomorrow for the ride up... ----- — On the far right of the c
Long
🟢 NEW POSITION $BTAI Target 37.60 for 30.1%$BTAI Target 37.60 for 30.1% Or double position at 20.20 I took this one earlier today… @28.90… Let’s see what happens… — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position w
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers